Viatris Change in Accounts Receivable 2010-2025 | VTRS

Viatris change in accounts receivable for the twelve months ending March 31, 2025 was $0.500B, a 223.19% increase year-over-year.

  • Viatris annual change in accounts receivable for 2024 was $0.3B, a 281.81% increase from 2023.
  • Viatris annual change in accounts receivable for 2023 was $0.079B, a 132.71% decline from 2022.
  • Viatris annual change in accounts receivable for 2022 was $-0.24B, a 505.23% decline from 2021.

Viatris Change in Accounts Receivable 2010-2025 | VTRS

  • Viatris annual change in accounts receivable for 2024 was $0.3B, a 281.81% increase from 2023.
  • Viatris annual change in accounts receivable for 2023 was $0.079B, a 132.71% decline from 2022.
  • Viatris annual change in accounts receivable for 2022 was $-0.24B, a 505.23% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$149.8B
CVS Health (CVS)$83.6B
Elevance Health (ELV)$66.3B
Cencora (COR)$56.4B
DiDi Global (DIDIY)$26.3B
Labcorp Holdings (LH)$22.6B
Natera (NTRA)$21.6B
BioMerieux (BMXMF)$17.2B
EUROFINS SCIENT (ERFSF)$14.9B
ICON (ICLR)$14.2B
CochLear (CHEOY)$13.3B
Medpace Holdings (MEDP)$13.1B
Solventum (SOLV)$12.9B
Revvity (RVTY)$10.6B
Caris Life Sciences,�Inc (CAI)$9.6B
Sonic Healthcare (SKHHY)$9.1B
Avantor (AVTR)$8.9B
HealthEquity (HQY)$7.7B
Charles River Laboratories (CRL)$7.6B
Bausch + Lomb (BLCO)$5B
Sotera Health (SHC)$4.5B
BrightSpring Health Services (BTSG)$4B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.5B
Surgery Partners (SGRY)$3B
Concentras Parent (CON)$2.9B
Alignment Healthcare (ALHC)$2.9B
Organon (OGN)$2.4B
Premier (PINC)$2B
Progyny (PGNY)$2B